# Isosorbide 5-Mononitrate

## Coxine 20mg

| TAH Drug Code      | [OCOX](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OCOX)                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prophylaxis of angina pectoris.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Dosing             | Initial dose: 5-10 mg (1/4-1/2 tablets) BID separate 7 hours apart for day 1 and day 2, then increase to 20 mg BID for 2 days. Maintain dose: 20 mg BID.                                                                                                                                                                                                                                                                                                                                                                                  |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Contraindications  | Allergy to nitrate. Obvious hypotension (systolic blood pressure <= 90mmHg), circulatory collapse, shock or cardiac shock, unless sufficient terminal diastolic blood pressure can be maintained, that is, by drugs that enhance myocardial contractility Or the balloon in the aorta beats in reverse to maintain blood pressure. Hypertrophic obstructive cardiomyopathy, stenotic pericarditis, aortic arch and mitral valve stenosis. Increase in intracranial pressure. Myocardial infarction with low ventricular filling pressure. |
| Adverse Effects    | Transient headache, nausea, dizziness, weakness, vomiting, tachycardia, decreased BP, possible formation of methemoglobin, rarely allergic skin reactions. Neurologic: Dizziness (8% to 11% ), Headache (38% to 57% )                                                                                                                                                                                                                                                                                                                     |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Moderate Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| More Info          | [UpToDate](https://www.uptodate.com/contents/isosorbide-mononitrate-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

